Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraprostatic botulinum toxin A for symptomatic benign prostatic hyperplasia
2010-022255-37Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of botulinum toxin type A in benign prostatic hyperplasia (BPH), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Change in urinary symptom severity by IPSS. Started Aug 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2010-022255-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022255-37.